Significance and treatment of asymptomatic bacteriuria during pregnancy

dc.contributor.authorHall D.R.
dc.contributor.authorTheron G.B.
dc.contributor.authorVan Der Horst W.
dc.date.accessioned2011-05-15T16:16:43Z
dc.date.available2011-05-15T16:16:43Z
dc.date.issued1997
dc.description.abstract[No abstract available]
dc.description.versionArticle
dc.identifier.citationInternational Journal of Gynecology and Obstetrics
dc.identifier.citation57
dc.identifier.citation2
dc.identifier.issn00207292
dc.identifier.other10.1016/S0020-7292(97)02819-1
dc.identifier.urihttp://hdl.handle.net/10019.1/13906
dc.subjectamoxicillin
dc.subjectcefradine
dc.subjectclavulanic acid
dc.subjecterythromycin
dc.subjectnalidixic acid
dc.subjectnitrofurantoin
dc.subjectsulfamethoxazole
dc.subjectarticle
dc.subjectasymptomatic bacteriuria
dc.subjectclinical trial
dc.subjectcohort analysis
dc.subjectdrug efficacy
dc.subjectfemale
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectpregnancy
dc.subjectpregnancy complication
dc.subjectpriority journal
dc.subjectAdult
dc.subjectAnti-Bacterial Agents
dc.subjectBacterial Infections
dc.subjectBacteriuria
dc.subjectCohort Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMicrobial Sensitivity Tests
dc.subjectPregnancy
dc.subjectPregnancy Complications, Infectious
dc.subjectTreatment Outcome
dc.titleSignificance and treatment of asymptomatic bacteriuria during pregnancy
dc.typeArticle
Files